Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Giovanni Luigi Di Maria Added: 2 years ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more
Research Area(s) / Expertise: Job title: Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine
Dr Federico Asch is the Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine (Cardiology) at Georgetown University. His research interests are: Myocardial viability in Ischemic Cardiomyopathy, Devices in Cardiovascular Diseases, Role of Echocardiography in clinical trials, and Contrast Echocardiography.a View more
Job title: Professor of Medicine and Radiology, and Director of the Cardiovascular Imaging Center
Job title: Assistant Professor of Medicine (Cardiology)
Roxy Senior is Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist and Director of Echocardiography at the Royal Brompton Hospital, London and Northwick Park Hospital, Harrow. He is a clinician with a major interest in echocardiography. He has been involved with echocardiography for the last 25 years and has published… View more
Added: 1 year ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary… View more
Added: 1 week ago Source:  Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a key clinical question. The iMODERN trial investigated whether an immediate intervention strategy was superior to a deferred approach in this patient population.¹The international, investigator-initiated, open-label iMODERN (Immediate or Deferred… View more